Policy / Pricing US pharma tariffs of up to 100% finalised by Trump PharmaphorumTrump signs his pharma tariffs executive order, which won't affect most large pharma groups but could deal a hefty blow to smaller companies.Policy / PricingRead full story pharminent April 3, 2026 (Last updated: April 3, 2026) Pharmaphorum Trump signs his pharma tariffs executive order, which won’t affect most large pharma groups but could deal a hefty blow to smaller companies. Policy / PricingRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Trump Hits Drugmakers With 100% Tariff but Carve-outs Soften the BlowNext: BioNTech Starts Shuttering Singapore mRNA Manufacturing Site Amid Pipeline Pivot Related Stories Policy / Pricing US generic tariff reprieve on the rocks as Trump proposes 100% rate in 2028 pharminent July 22, 2026 Policy / Pricing UK commits to pharma IP protection in Swiss trade deal pharminent July 16, 2026 Policy / Pricing Germany approves healthcare costs overhaul despite significant pharma opposition pharminent July 13, 2026
